12/28/2023 0 Comments Glucagon copay assistance programs![]() ![]() have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.If you have heart failure, it may get worse while you take TZDs (thiazolidinediones) with Xultophy ® 100/3.6. have heart failure or other heart problems.have or have had problems with your pancreas, kidneys, or liver.Tell your health care provider about all your medical conditions, including if you: What should I tell my health care provider before using Xultophy ® 100/3.6? you are having an episode of low blood sugar or if you are allergic to insulin degludec, liraglutide, or any of the ingredients in Xultophy ® 100/3.6.you or any of your family have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).It is not known if Xultophy ® 100/3.6 will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people. In studies with rats and mice, liraglutide, one of the components of Xultophy ® 100/3.6, and medicines that work like liraglutide caused thyroid tumors, including thyroid cancer. Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.Xultophy ® 100/3.6 may cause serious side effects, including: Xultophy ® 100/3.6 Important Safety Information What is the most important information I should know about Xultophy ® 100/3.6? It is not known if Xultophy ® 100/3.6 is safe and effective for use in children.It is not known if Xultophy ® 100/3.6 can be used with mealtime insulin.Xultophy ® 100/3.6 is not for use in people with type 1 diabetes or people with diabetic ketoacidosis (increased ketones in the blood or urine).Xultophy ® 100/3.6 is not recommended for use in combination with any other product containing liraglutide or another glucagon like peptide 1 receptor agonist (GLP-1 RA).Xultophy ® 100/3.6 is not recommended as the first choice of medicine for treating diabetes.Xultophy ® 100/3.6 should be used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes mellitus. Xultophy ® 100/3.6 is an injectable prescription medicine that contains 2 diabetes medicines, insulin degludec, 100 units/mL, and liraglutide, 3.6 mg/mL. What is Xultophy ® 100/3.6 (insulin degludec and liraglutide) injection 100 units/mL and 3.6 mg/mL? ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |